A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection.
The Journal of infectious diseases（2023）
摘要
NCT04487444.
更多查看译文
关键词
COVID-19,efficacy,hypoxemia,lymphocytopenia,lymphopenia,safety,thymalfasin,thymosin-α-1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要